Basics Fortress Biotech, Inc. Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing and commercializing pharmaceutical and biotechnology products. IPO Date: December 1, 2011 Sector: Healthcare Industry: Biotech Market Cap: $110.39M Activated in VL: True Average Daily Range Avg Daily Range: $0.08 | 3.64% Avg Daily Range (30 D): $0.08 | 3.24% Avg Daily Range (90 D): $0.06 | 2.78% Institutional Daily Volume Avg Daily Volume: .41M Avg Daily Volume (30 D): .64M Avg Daily Volume (90 D): .34M Trade Size Avg Trade Size (Sh.): 218 Avg Trade Size (Sh.) (30 D): 253 Avg Trade Size (Sh.) (90 D): 243 Institutional Trades Total Inst.Trades: 36 Avg Inst. Trade: $2.41M Avg Inst. Trade (30 D): $.69M Avg Inst. Trade (90 D): $.69M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.49M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 11.5K     News May 30, 2025 @ 2:47 PM Fortress Biotech Announces Closing of Sale of Subs... Source: Globe Newswire May 7, 2025 @ 12:00 PM Fortress Biotech to Participate in the H.C. Wainwr... Source: N/A Feb 10, 2025 @ 1:00 PM Mustang Bio Announces Closing of $8 Million Public... Source: N/A Feb 6, 2025 @ 12:00 PM Mustang Bio Announces Pricing of $8 Million Public... Source: Globe Newswire Feb 6, 2025 @ 12:00 PM Mustang Bio Announces Pricing of $8 Million Public... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1 $.5 $-.48 Diluted EPS $-1 $.45 $-.48 Revenue $ 59.3M $ 16.41M $ 13.14M Gross Profit $ 42.05M $ 11.47M $ 8.35M Net Income / Loss $ -89.35M $ -11.65M $ -24.69M Operating Income / Loss $ -104.72M $ -36.47M $ -22.32M Cost of Revenue $ 17.25M $ 4.94M $ 4.79M Net Cash Flow $ -7.76M $ -16.95M $ 33.74M PE Ratio     Splits Oct 10, 2023:   1:15 Dec 06, 2022:   1:10